MaxLinear (NASDAQ:MXL) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $22.58, along with a high estimate of $28.00 and a low estimate of $14.00. Marking an increase of 1.71%, the current average surpasses the previous average price target of $22.20.

Exploring Analyst Ratings: An In-Depth Overview

The analysis of recent analyst actions sheds light on the perception of MaxLinear by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MaxLinear's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on MaxLinear analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

About MaxLinear

Unraveling the Financial Story of MaxLinear

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Negative Revenue Trend: Examining MaxLinear's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately -40.16% in revenue growth, reflecting a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.

Net Margin: MaxLinear's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -93.44%, the company may face hurdles in effective cost management.

Return on Equity (ROE): MaxLinear's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -12.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): MaxLinear's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -8.11%, the company may encounter challenges in delivering satisfactory returns from its assets.

Debt Management: With a below-average debt-to-equity ratio of 0.27, MaxLinear adopts a prudent financial strategy, indicating a balanced approach to debt management.

Understanding the Relevance of Analyst Ratings

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.